tyme technologies stock price target

6558 of MarketBeat users gave Tyme Technologies an outperform vote while medical companies recieve an average of 6744 outperform votes by MarketBeat users. Find the latest Tyme Technologies Inc.

Revisiting Tyme Technologies Nasdaq Tyme Seeking Alpha

That rank is mainly influenced by a fundamental score of 0.

. The current price of Tyme Technologies is the price at which Tyme Technologies is currently trading. Find the latest Tyme Technologies Inc. The latest price target for.

Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States. The companys stock has been forecasted to trade at an average price of 800 over the course of the next 52 weeks with a low of 800 and a high of 800. The average TYME stock price target is 950 with a high estimate of 950 and a low estimate of 950.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Tyme Technologies stock was trading at 105 on March 11th 2020 when Coronavirus reached pandemic status according to the World Health Organization. Tyme Technologies NASDAQTYME Price Target and Consensus Rating.

Given the current short-term trend the stock is expected to fall -5829 during the next 3 months and with a 90 probability hold a price between 00687 and 016 at the end of this 3-month period. The company also offers TYME-19 an. Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma.

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Tyme Technologies Inc have a median target of 800 with a high estimate of 800 and a low estimate of 800. TYME analyst stock forecast price target and recommendation trends with in-depth analysis from research. Find the latest Tyme Technologies Inc TYME stock price forecast 12-month price target predictions and analyst recommendations.

During the day the stock fluctuated 533 from a day low at 033 to a day high of 035. Based on these price targets the low is -225294 off current price whereas the price has to move -225294 to reach the yearly target high. The Company is focused on developing cancer metabolism-based therapies CMBTs for a range of solid tumors and hematologic cancers.

The successful prediction of Tyme Technologies future price could yield a significant profit. 45 rows Tyme Technologies Incs average analyst price target is higher than 1754 of all US. Tyme Technologies stock price prediction is an act of determining the future value of Tyme Technologies shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation.

AFTER HOURS 621 PM EST 021122. TYME stock has a mean target price of 950. The company also offers TYME-19 an.

USD 031 003 882. The average price target is 000 with a high estimate of 000 and a low estimate of 000. AFTER HOURS Vol 15891.

The Tyme Technologies Inc stock price fell by -032 on the last day Friday 18th Feb 2022 from 034 to 034. 1 Wall Street analysts that have issued a 1 year TYME price target the average TYME price target is 950 with the highest TYME stock price forecast at 950 and the lowest TYME stock price forecast at 950 Find the latest Tyme Technologies Inc. TYME was reported by Canaccord Genuity on January 4 2018.

The Companys lead clinical CMBT compound SM-88 is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic. Based on analysts offering 12 month price targets for TYME in the last 3 months. MarketBeat users like Tyme Technologies stock less than the stock of other Medical companies.

TYME stock quote history news and other vital information to help you with your stock trading and investing. Tyme Technologies Inc. 1 Wall Street analyst that have issued a 1 year TYME price target the average TYME price target is 950 with the highest TYME stock price forecast at 950 and the lowest TYME stock price forecast at 950.

The analyst firm set a price target for 1000 expecting TYME to rise to within. TYME real-time stock quote data in-depth charts and a fully built financial calendar to help you invest smart. Nasdaq AT CLOSE 400 PM EST 021122.

Tyme Technologies Inc stock is unchanged 000 over the last 12 monthsInvestorsObservers proprietary ranking system gives TYME stock a score of 10 out of a possible 100. Tyme Technologies Target Price Projection Tyme Technologies current and average target prices are 031 and 883 respectively. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States.

Webull offers Tyme Technologies Inc TYME historical stock prices in-depth market analysis NASDAQ. On the other hand Tyme Technologies target price is what analysts think the stock is worth or could sell for in the future. TYME stock quote history news and other vital information to help you with your stock trading and investing.

Ad 1000 Strong Buy Stocks that Double the SP. Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma. 31 rows TYME Stock Trend.

Is a biotechnology company. How has Tyme Technologies stock price been impacted by Coronavirus. The price has fallen in 6 of the last 10 days and is down by.

Tyme Stock Price And Chart Nasdaq Tyme Tradingview